Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures - Operating Segments (Details)

v3.20.1
Segment Disclosures - Operating Segments (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
segment
Mar. 31, 2019
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 2  
Revenue $ 1,468 $ 3,616
Cost of revenue 831 2,017
Gross profit 637 1,599
Operating Segments    
Segment Reporting Information [Line Items]    
Revenue 1,468 3,616
Cost of revenue 831 2,017
Gross profit 637 1,599
EksoHealth | Operating Segments    
Segment Reporting Information [Line Items]    
Revenue 1,191 2,814
Cost of revenue 618 1,300
Gross profit 573 1,514
EksoWorks | Operating Segments    
Segment Reporting Information [Line Items]    
Revenue 277 802
Cost of revenue 213 717
Gross profit $ 64 $ 85